Pharma Engagement Strategy with IDNs – Embedding in Clinical PathwaysBig Pharma, Clinical Pathways, Clinical Trials, Healthcare Physicians, integrated h, Issue Archives, June 2016, Off Label Usage, Oncology, Physicians, R&DWhile every medical case is unique, payers and providers are attempting to standardize treatment since unnecessary variation is a major source of growing costs. Read more March 25, 2016/by Administrator https://www.pharmalive.com/wp-content/uploads/2016/03/Partha-Anbil-Headshot.jpg 192 288 Administrator https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Administrator2016-03-25 16:53:252016-06-09 02:07:11Pharma Engagement Strategy with IDNs – Embedding in Clinical Pathways